骨髓腔内输液通路在急危重症病人中的研究进展  

Research progress on intramedullary infusion access in critically ill patients

作　　者：叶群 邹晓月[2] 潘晓巍 周慧 凌敏 毛家慧 YE Qun;ZOU Xiaoyue;PAN Xiaowei;ZHOU Hui;LING Min;MAO Jiahui(Huzhou University,Zhejiang 313000,China)

机构地区：[1]湖州师范学院,313000 [2]湖州市第一人民医院,313000

出　　处：《全科护理》2022年第20期2756-2760,共5页Chinese General Practice Nursing

摘　　要：骨髓腔内输液(intraosseous infusion)通路指的是将一根特殊的中空穿孔针穿过骨皮质进入骨髓腔,以便进行药物治疗和实验室检查。当人们遇到心搏骤停、创伤、休克、恶性心律失常、水肿、癫痫等情况时,外周静脉通常会发生塌陷,骨髓腔内输液则可以达到快速而安全地输送液体、药物和血液产品。本文从骨髓腔内输液通路的发展史、适应证和禁忌证、穿刺设备选择、穿刺部位以及并发症的预防5个方面进行了相应阐述。The Intraosseous Infusion(IO)pathway refers to the insertion of a special hollow,perforated needle through the bone cortex into the bone marrow cavity for drug treatment and laboratory tests.When people suffer from cardiac arrest,trauma,shock,malignant arrhythmias,edema,epilepsy,and other conditions,peripheral veins often collapse,and intramedullary infusion can achieve rapid and safe delivery of fluids,drugs,and blood products.This article reviewed intraosseous infusion from the aspects of development history,indications and contraindications,selection of puncture equipment,puncture sites,and prevention of complications.

关 键 词：骨髓腔通路 危重症病人 综述 

分 类 号：R473[医药卫生—护理学]